Lipoprotein(a) Lp(a)

Lipoprotein(a) [Lp(a)] is a genetically determined lipid particle recognised as an independent driver of cardiovascular risk, even when other lipid levels are well controlled. The Lp(a) Knowledge Track curates expert-selected resources — from epidemiological studies and clinical discussions to measurement guidance, therapeutic perspectives, and expert debates. It provides clarity on Lp(a)’s role in cardiovascular risk, supporting your awareness of testing challenges and exploring strategies that may inform your future management decisions.

 

ESC content

31 August 2024 08:27 CET Europe/Paris Thirty-year cardiovascular outcomes in women based on C-reactive protein, LDL cholesterol, and lipoprotein(a) Access event page https://esc365.escardio.org/event/undefined 2024-08-31T08:27:00 2024-08-31T08:40:00
Open Access

Thirty-year cardiovascular outcomes in women based on C-reactive protein, LDL cholesterol, and lipoprotein(a)

1 September 2024 14:35 CET Europe/Paris A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study Access event page https://esc365.escardio.org/event/undefined 2024-09-01T14:35:00 2024-09-01T14:47:00
Open Access

A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study

25 August 2023 17:06 CET Europe/Paris Why measure Lp(a) and what to do about it? Access event page https://esc365.escardio.org/event/undefined 2023-08-25T17:06:00 2023-08-25T17:18:00
Open Access

Why measure Lp(a) and what to do about it?

1 September 2024 11:12 CET Europe/Paris Strategies to inhibit Lp(a) Access event page https://esc365.escardio.org/event/undefined 2024-09-01T11:12:00 2024-09-01T11:24:00
Open Access

Strategies to inhibit Lp(a)

2 September 2024 10:00 CET Europe/Paris Coronary atherosclerotic plaque burden and characterization by spectral computed tomography scan in patients with high lipoprotein a and non-hemodynamically significant stenosis Access event page https://esc365.escardio.org/event/undefined 2024-09-02T10:00:00 2024-09-02T10:50:00
Open Access

Coronary atherosclerotic plaque burden and characterization by spectral computed tomography scan in patients with high lipoprotein a and non-hemodynamically significant stenosis

2 September 2024 15:30 CET Europe/Paris Lp(a) and aortic stenosis: epidemiology Access event page https://esc365.escardio.org/event/undefined 2024-09-02T15:30:00 2024-09-02T15:45:00
Open Access

Lp(a) and aortic stenosis: epidemiology

26 August 2023 11:15 CET Europe/Paris Lipoprotein(a) and the risk of major adverse limb events in patients with stable atherosclerotic vascular disease Access event page https://esc365.escardio.org/event/undefined 2023-08-26T11:15:00 2023-08-26T12:00:00
Open Access

Lipoprotein(a) and the risk of major adverse limb events in patients with stable atherosclerotic vascular disease

29 August 2022 16:49 CET Europe/Paris Lp(a) clinical case scenarios. Access event page https://esc365.escardio.org/event/undefined 2022-08-29T16:49:00 2022-08-29T16:54:00
Open Access

Lp(a) clinical case scenarios.

29 August 2022 16:34 CET Europe/Paris Lp(a) in clinical practice-risk estimation and how to reduce its associated risk. Access event page https://esc365.escardio.org/event/undefined 2022-08-29T16:34:00 2022-08-29T16:49:00
Open Access

Lp(a) in clinical practice-risk estimation and how to reduce its associated risk.

30 August 2024 12:30 CET Europe/Paris Cases in Lp(a) – primary and secondary prevention Access event page https://esc365.escardio.org/event/undefined 2024-08-30T12:30:00 2024-08-30T12:50:00
Open Access

Cases in Lp(a) – primary and secondary prevention

27 August 2022 11:50 CET Europe/Paris Lipoprotein(a) in progressive coronary artery disease: beyond classical cardiovascular risk parameters Access event page https://esc365.escardio.org/event/undefined 2022-08-27T11:50:00 2022-08-27T12:00:00
Open Access

Lipoprotein(a) in progressive coronary artery disease: beyond classical cardiovascular risk parameters

2 September 2024 15:15 CET Europe/Paris Lp(a) and aortic stenosis: biological underpinnings Access event page https://esc365.escardio.org/event/undefined 2024-09-02T15:15:00 2024-09-02T15:30:00
Open Access

Lp(a) and aortic stenosis: biological underpinnings

28 August 2022 10:15 CET Europe/Paris Targeting Lp(a) in CV risk reduction: where are we now? Access event page https://esc365.escardio.org/event/undefined 2022-08-28T10:15:00 2022-08-28T10:25:00
Open Access

Targeting Lp(a) in CV risk reduction: where are we now?